Saturday, October 17, 2026 · Edition updated 6:00 AM ETSAT, OCT 17 · 6 AM ET editionNext edition in Next --:--:--

Care plan study for frail adults with heart failure is recruiting

Recruiting · Vestre Viken Hospital Trust

What this means

Researchers plan to test a team-based care plan for frail people with heart failure. The study has not reported results, so it cannot yet show whether the plan helps.

Plain-English summary written by an AI model from the registry listing.

Status
Recruiting
Who can join
Ages 18 and over · 20 frail heart failure patients, with 40 matched control patients planned
Where
1 site

Contacts and how to join ↗

The science

Registered title
INTEgRated Health CARE for Patients With Frailty and Heart Failure
Phase
Not applicable
Study type
interventional
Conditions
Heart Failure, Frailty, Frail Elderly Syndrome, Symptom, Behavioral, Utilization, Health Care, Quality of Life
What is tested
INTERCARE-HF
Sponsor
Vestre Viken Hospital Trust
Ages
18 Years to no maximum
Dates
First posted Jun 5, 2024 · updated Jun 13, 2024

Registry summary

Frailty, an aging-related syndrome of physiological decline characterized by marked vulnerability to adverse health outcomes, has attracted increasing attention in cardiology due to the growing elderly population with heart failure. Frail patients are mainly excluded from large cardiovascular intervention studies, and clinical trials addressing frailty and showing an impact on treatment on symptom burden, quality of life and /or outcome has been requested in recent guidelines and consensus documents. The INTEgrRated health CARE for patients with severe frailty and Heart Failure (INTERCARE-HF) is a proof-of-concept study that aims to evaluate the effect of integrated healthcare services for heart failure patients with a severe level of frailty by establishing interdisciplinary and coordinated follow-up teams across the healthcare boundaries. These teams will assess the patient's needs, goals, and risk areas, conduct advance care planning, and develop individualized treatment and follow-up plans. An open-label, non-randomized intervention study aims to recruit 20 patients and heart failure and a clinical Frailty Score (CSF) >=5. A control-group (N=40) matched on age an clinical frailty scale score will be included. The overall hypothesis is that the intervention is feasible in routine clinical practice with favorable effects on quality of life, symptoms, caregiver distress, and healthcare service utilization.

Sites (1)

  • Drammen Hospital, Drammen, Akershus, Norway
Report a problem